Lymphovascular and neural regulation of metastasis: shared tumour signalling pathways and novel therapeutic approaches

Best Pract Res Clin Anaesthesiol. 2013 Dec;27(4):409-25. doi: 10.1016/j.bpa.2013.10.008. Epub 2013 Oct 15.

Abstract

The progression of cancer is supported by a wide variety of non-neoplastic cell types which make up the tumour stroma, including immune cells, endothelial cells, cancer-associated fibroblasts and nerve fibres. These host cells contribute molecular signals that enhance primary tumour growth and provide physical avenues for metastatic dissemination. This article provides an overview of the role of blood vessels, lymphatic vessels and nerve fibres in the tumour microenvironment and highlights the interconnected molecular signalling pathways that control their development and activation in cancer. Further, this article highlights the known pharmacological agents which target these pathways and discusses the potential therapeutic uses of drugs that target angiogenesis, lymphangiogenesis and stress-response pathways in the different stages of cancer care.

Keywords: NSAID; SNS; angiogenesis; beta-blocker; lymphangiogenesis; nerve fibres; sympathetic nervous system; vasculature.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Disease Progression
  • Drug Design
  • Humans
  • Lymphangiogenesis / drug effects
  • Molecular Targeted Therapy*
  • Neoplasm Metastasis
  • Neoplasms / drug therapy
  • Neoplasms / pathology*
  • Neovascularization, Pathologic / drug therapy
  • Neovascularization, Pathologic / pathology
  • Signal Transduction / drug effects
  • Stress, Physiological / drug effects
  • Tumor Microenvironment

Substances

  • Antineoplastic Agents